Corcept Therapeutics (CORT) total debt

Total debt · fiscal 2025
$6.11M

Corcept Therapeutics (CORT) carried total debt of $6.11M at the end of fiscal 2025 (December 31, 2025). That is 12.0% lower than the $6.94M of fiscal 2024. Figures as of 18 Nov 2026, 02:52 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$6.11M
Change on fiscal 2024
−12.0%
Growth, 10 years
−14.0% a year
Highest on record
$45.00Mfiscal 2012
Lowest on record
$0.00fiscal 2017
Fiscal years on record
102012–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Corcept Therapeutics total debt, in more detail

Over the ten fiscal years to 2025 total debt shrank at a compound 14.0% a year. Across the 10 fiscal years on record (2012–2025), the highest was $45.00M in fiscal 2012 and the lowest $0.00 in fiscal 2017.

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

History · 10 fiscal years

Total debt by fiscal year

Corcept Therapeutics total debt, year by year

Corcept Therapeutics (CORT) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$6.11M 12.0% down0.0×
2024$6.94M 4,493.4% up0.0×
2023$151.00K 86.8% down0.0×
2022$1.14M—0.0×
2017$0.00 100.0% down0.0×
2016$14.66M 46.7% down0.4×
2015$27.49M 18.9% down1.5×
2014$33.89M 3.4% down—
2013$35.07M 22.1% down1.7×
2012$45.00M—0.7×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Corcept Therapeutics and comparable companies
CompanyTotal debtFiscal year
10x Genomics TXG$84.36M2025
HealthEquity HQY$1.00B2026
Corcept Therapeutics CORT$6.11M2025
Rhythm Pharmaceuticals RYTM$3.99M2025
Alkermes ALKS$70.00M2025
PACS Group PACS$3.47B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CORT

Corcept Therapeutics, figure by figure

Corcept Therapeutics (CORT) overview: price, valuation and scorecardAll health care companies by market value

Corcept Therapeutics total debt: questions and answers

How much debt does Corcept Therapeutics have?

Corcept Therapeutics (CORT) carried total debt of $6.11M at the end of fiscal 2025 (December 31, 2025). That is 12.0% lower than the $6.94M of fiscal 2024.

What is the growth rate of Corcept Therapeutics's total debt?

Over the ten fiscal years to 2025 total debt shrank at a compound 14.0% a year.

What are the highest and lowest total debt figures on record for Corcept Therapeutics?

Across the 10 fiscal years on record (2012–2025), the highest was $45.00M in fiscal 2012 and the lowest $0.00 in fiscal 2017.

How does Corcept Therapeutics's debt compare with its equity?

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

How is Corcept Therapeutics's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Corcept Therapeutics (CORT) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/CORT/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.